Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohd Imran, Shah Alam Khan, Abida, Ahmed Subeh Alshrari, Mahmoud Mudawi Eltahir Mudawi, Mohammed Kanan Alshammari, Aishah Ali Harshan & Noufah Aqeel Alshammari. (2022) Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021. Expert Opinion on Therapeutic Patents 32:5, pages 591-604.
Read now
Read now
Yu Cao, Huajian Zhu, Ruoyu He, Limin Kong, Jiaan Shao, Rangxiao Zhuang, Jianjun Xi & Jiankang Zhang. (2020) Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer. Drug Design, Development and Therapy 14, pages 4327-4342.
Read now
Read now
Articles from other publishers (21)
Mojtaba Rostamighadi, Arezou Kamelshahroudi, Vaibhav Mehta, Fu-Yue Zeng, Ian Pass, Thomas D.Y. Chung & Reza Salavati. (2024) High-throughput screening of compounds targeting RNA editing in Trypanosoma brucei: Novel molecular scaffolds with broad trypanocidal effects. Biochemical Pharmacology 219, pages 115937.
Crossref
Crossref
Sarah Nathaly Wieser, Cecilia Decker-Franco, Paloma de Alba, Sandra Romero, Alejandro Ferrari, Leonhard Schnittger & Mónica Florin-Christensen. (2023) Discovery of Antigens and Cellular Mechanisms in the Protozoan Parasite Sarcocystis aucheniae Using Immunoproteomics. Parasitologia 3:4, pages 349-363.
Crossref
Crossref
Monica Florin-Christensen, Daniel Sojka, Sabrina Ganzinelli, Pavla Šnebergerová, Carlos E. Suarez & Leonhard Schnittger. (2023) Degrade to survive: the intricate world of piroplasmid proteases. Trends in Parasitology 39:7, pages 532-546.
Crossref
Crossref
Philip J. Rosenthal. (2023) Proteasome inhibitors: The next generation of antimalarial drugs?. Cell Chemical Biology 30:5, pages 413-415.
Crossref
Crossref
Ioanna Deni, Barbara H. Stokes, Kurt E. Ward, Kate J. Fairhurst, Charisse Flerida A. Pasaje, Tomas Yeo, Shirin Akbar, Heekuk Park, Ryan Muir, Daniella S. Bick, Wenhu Zhan, Hao Zhang, Yi Jing Liu, Caroline L. Ng, Laura A. Kirkman, Jehad Almaliti, Alexandra E. Gould, Maëlle Duffey, Anthony J. O'Donoghue, Anne-Catrin Uhlemann, Jacquin C. Niles, Paula C.A. da Fonseca, William H. Gerwick, Gang Lin, Matthew Bogyo & David A. Fidock. (2023) Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome. Cell Chemical Biology 30:5, pages 470-485.e6.
Crossref
Crossref
Li He, Hong-Run Zhang, Wen-Da Di, Fang-Fang Li, Chun-Qun Wang, Xin Yang, Xiao-Fang Liu & Min Hu. (2023) A proteasomal β5 subunit of Haemonchus contortus with a role in the growth, development and life span. Parasites & Vectors 16:1.
Crossref
Crossref
Rocío Marisol Espinoza-Chávez, Alessandra Salerno, Anastasia Liuzzi, Andrea Ilari, Andrea Milelli, Elisa Uliassi & Maria Laura Bolognesi. (2022) Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery. ACS Bio & Med Chem Au 3:1, pages 32-45.
Crossref
Crossref
Dennis C. Koester, Vanessa M. Marx, Sarah Williams, Jan Jiricek, Maxime Dauphinais, Olivier René, Sarah L. Miller, Lei Zhang, Debjani Patra, Yen-Liang Chen, Harry Cheung, Jonathan Gable, Suresh B. Lakshminarayana, Colin Osborne, Jean-Rene Galarneau, Upendra Kulkarni, Wendy Richmond, Angela Bretz, Linda Xiao, Frantisek Supek, Christian Wiesmann, Srinivas Honnappa, Celine Be, Pascal Mäser, Marcel Kaiser, Ryan RitchieMichael P. BarrettThierry T. Diagana, Christopher Sarko & Srinivasa P. S. Rao. (2022) Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT). Journal of Medicinal Chemistry 65:17, pages 11776-11787.
Crossref
Crossref
Jing Wu, Fang Zhang, Hongji Tao, Waqas Nawaz, Deyan Chen & Zhiwei Wu. (2022) The potential roles of interleukin-25 in infectious diseases. Frontiers in Immunology 13.
Crossref
Crossref
Juliana Almeida-Silva, Diego Silva Menezes, Juan Mateus Pereira Fernandes, Márcio Cerqueira Almeida, Deyvison Rhuan Vasco-dos-Santos, Roberto Magalhães Saraiva, Alessandra Lifsitch Viçosa, Sandra Aurora Chavez Perez, Sônia Gumes Andrade, Ana Márcia Suarez-Fontes & Marcos André Vannier-Santos. (2022) The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
George Kobakhidze, Ashish Sethi, Sepideh Valimehr, Stuart A. Ralph & Isabelle Rouiller. (2022) The AAA+ ATPase p97 as a novel parasite and tuberculosis drug target. Trends in Parasitology 38:7, pages 572-590.
Crossref
Crossref
Binghui Jin, Guangyao Li, Lin Zhou & Zhe Fan. (2022) Mechanism Involved in Acute Liver Injury Induced by Intestinal Ischemia-Reperfusion. Frontiers in Pharmacology 13.
Crossref
Crossref
Elya Dekel, Dana Yaffe, Irit Rosenhek-Goldian, Gili Ben-Nissan, Yifat Ofir-Birin, Mattia I. Morandi, Tamar Ziv, Xavier Sisquella, Matthew A. Pimentel, Thomas Nebl, Eugene Kapp, Yael Ohana Daniel, Paula Abou Karam, Daniel Alfandari, Ron Rotkopf, Shimrit Malihi, Tal Block Temin, Debakshi Mullick, Or-Yam Revach, Ariel Rudik, Nir S. Gov, Ido Azuri, Ziv Porat, Giulia Bergamaschi, Raya Sorkin, Gijs J. L. Wuite, Ori Avinoam, Teresa G. Carvalho, Sidney R. Cohen, Michal Sharon & Neta Regev-Rudzki. (2021) 20S proteasomes secreted by the malaria parasite promote its growth. Nature Communications 12:1.
Crossref
Crossref
Violeta Kourbeli, Eleni Chontzopoulou, Kalliopi Moschovou, Dimitrios Pavlos, Thomas Mavromoustakos & Ioannis P. Papanastasiou. (2021) An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Molecules 26:15, pages 4629.
Crossref
Crossref
Michal Sharon & Neta Regev‐Rudzki. (2021) Cell communication and protein degradation: All in one parasitic package. Journal of Extracellular Vesicles 10:9.
Crossref
Crossref
Lydia Mata-Cantero, Stanley C. Xie, Mercedes García, Joanne Coyle, Raquel Fernandez, Alvaro Cortes Cabrera, David L. Gillett, Benigno Crespo, Francisco-Javier Gamo, Esther Fernández, Leann Tilley & Maria G. Gomez-Lorenzo. (2021) High Throughput Screening to Identify Selective and Nonpeptidomimetic Proteasome Inhibitors As Antimalarials. ACS Infectious Diseases 7:6, pages 1818-1832.
Crossref
Crossref
Manish T. Shrivastav, Zainab Malik & Somlata. (2021) Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Andrew M. Thompson, Patrick D. O’Connor, Vanessa Yardley, Louis Maes, Delphine Launay, Stephanie Braillard, Eric Chatelain, Baojie Wan, Scott G. Franzblau, Zhenkun Ma, Christopher B. Cooper & William A. Denny. (2021) Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility. ACS Medicinal Chemistry Letters 12:2, pages 275-281.
Crossref
Crossref
Igor A. Rodrigues, Andreza R. Garcia, Mariana M. Paz, Rogério G. D. Grilo Junior, Ana Claudia F. Amaral & Anderson S. Pinheiro. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
143
180
.
Matshawandile Tukulula, Stefan Louw, Mathew Njoroge & Kelly Chibale. (2020) Synthesis and In Vitro Antiprotozoan Evaluation of 4-/8-Aminoquinoline-based Lactams and Tetrazoles. Molecules 25:24, pages 5941.
Crossref
Crossref
Grace E. Hubbell & Jetze J. Tepe. (2020) Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors. RSC Chemical Biology 1:5, pages 305-332.
Crossref
Crossref